Literature DB >> 16134984

Antibacterial properties of larval secretions of the blowfly, Lucilia sericata.

A Kerridge1, H Lappin-Scott, J R Stevens.   

Abstract

The antibacterial properties of secretions aseptically collected from larvae of the greenbottle fly Lucilia sericata (Meigen) (Diptera: Calliphoridae) were examined. These investigations revealed the presence of small (<1 kDa) antibacterial factor(s) within the larval secretions, active against a range of bacteria. These include the Gram-positive Staphylococcus aureus, both methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-sensitive Staphylococcus aureus (MSSA), Streptococcus pyogenes and to a lesser extent the Gram-negative Pseudomonas aeruginosa. These secretions were shown to be highly stable as a freeze-dried preparation and, considering the activity against organisms typically associated with clinical infection, may be a source of novel antibiotic-like compounds that may be used for infection control and in the fight against MRSA.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16134984     DOI: 10.1111/j.1365-2915.2005.00577.x

Source DB:  PubMed          Journal:  Med Vet Entomol        ISSN: 0269-283X            Impact factor:   2.739


  27 in total

1.  The insect defensin lucifensin from Lucilia sericata.

Authors:  Mads Kristian Erlin Nygaard; Anders Schou Andersen; Hans-Henrik Kristensen; Karen Angeliki Krogfelt; Peter Fojan; Reinhard Wimmer
Journal:  J Biomol NMR       Date:  2012-03       Impact factor: 2.835

2.  Maggot therapy following orbital exenteration.

Authors:  Adrian Gericke; Esther M Hoffmann; Susanne Pitz; Norbert Pfeiffer
Journal:  Br J Ophthalmol       Date:  2007-12       Impact factor: 4.638

3.  The potential use of bacterial community succession in forensics as described by high throughput metagenomic sequencing.

Authors:  Jennifer L Pechal; Tawni L Crippen; M Eric Benbow; Aaron M Tarone; Scot Dowd; Jeffery K Tomberlin
Journal:  Int J Legal Med       Date:  2013-06-10       Impact factor: 2.686

4.  Maggot excretions/secretions induces human microvascular endothelial cell migration through AKT1.

Authors:  Shou-yu Wang; Kai Wang; Yi Xin; De-cheng Lv
Journal:  Mol Biol Rep       Date:  2009-09-16       Impact factor: 2.316

Review 5.  TIME management by medicinal larvae.

Authors:  David I Pritchard; Václav Čeřovský; Yamni Nigam; Samantha F Pickles; Gwendolyn Cazander; Peter H Nibbering; Anke Bültemann; Wilhelm Jung
Journal:  Int Wound J       Date:  2015-07-15       Impact factor: 3.315

6.  Maggots reveal a case of antemortal insect infestation.

Authors:  Kristina Baumjohann; Karl-Heinz Schiwy-Bochat; Markus Alexander Rothschild
Journal:  Int J Legal Med       Date:  2011-05-02       Impact factor: 2.686

7.  First Record of Larval Secretions of Cochliomyia macellaria (Fabricius, 1775) (Diptera: Calliphoridae) Inhibiting the Growth of Staphylococcus aureus and Pseudomonas aeruginosa.

Authors:  F S Masiero; M F K Aquino; M P Nassu; D I B Pereira; D S Leite; P J Thyssen
Journal:  Neotrop Entomol       Date:  2016-10-01       Impact factor: 1.434

8.  Maggot debridement therapy with Lucilia cuprina: a comparison with conventional debridement in diabetic foot ulcers.

Authors:  Aaron G Paul; Nazni W Ahmad; H L Lee; Ashraff M Ariff; Masri Saranum; Amara S Naicker; Zulkiflee Osman
Journal:  Int Wound J       Date:  2009-02       Impact factor: 3.315

9.  A novel approach to the antimicrobial activity of maggot debridement therapy.

Authors:  Anders S Andersen; Dorthe Sandvang; Kirk M Schnorr; Thomas Kruse; Søren Neve; Bo Joergensen; Tonny Karlsmark; Karen A Krogfelt
Journal:  J Antimicrob Chemother       Date:  2010-06-11       Impact factor: 5.790

10.  Quorum-sensing-regulated virulence factors in Pseudomonas aeruginosa are toxic to Lucilia sericata maggots.

Authors:  A S Andersen; B Joergensen; T Bjarnsholt; H Johansen; T Karlsmark; M Givskov; K A Krogfelt
Journal:  Microbiology (Reading)       Date:  2009-11-05       Impact factor: 2.777

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.